Bisoprolol Fumarate 5 MG Oral Tablet
INDICATIONS AND USAGE Bisoprolol fumarate tablets, USP are indicated in the management of hypertension. It may be used alone or in combination with other antihypertensive agents.
Eon Labs, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Bisoprolol Fumarate Tablets, USP, for oral administration, are available as 5 mg pink, round, biconvex, film-coated, debossed “ E ” over “771” and bisected on the other side and supplied as: NDC 0185-0771-30 bottles of 30 NDC 0185-0771-01 bottles of 100 10 mg white, round, biconvex, film-coated, debossed “ E ” over “774” and plain on the other side and supplied as: NDC 0185-0774-30 bottles of 30 NDC 0185-0774-01 bottles of 100 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure, as required. KEEP TIGHTLY CLOSED. To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Manufactured by Sandoz Inc. Princeton, NJ 08540 46192536 Rev. September 2016 MF0771REV09/16
More pills like ROUND E 771